159 related articles for article (PubMed ID: 3305206)
1. Remission induction with cytarabine and daunorubicin with or without 6-thioguanine in adult patients with acute myelocytic leukemia.
Nowrousian MR; Pfeiffer R; Schaefer UW; Osieka R; Niederle N; Anders C; Schmidt CG
Haematol Blood Transfus; 1987; 30():352-5. PubMed ID: 3305206
[No Abstract] [Full Text] [Related]
2. Treatment of acute myelocytic leukemia with a daunorubicin-cytarabine-6 thioguanine regimen without maintenance therapy.
Freund M; Poliwoda H; Bodenstein H; Eisert R
Onkologie; 1985 Jun; 8(3):150-2. PubMed ID: 3895097
[TBL] [Abstract][Full Text] [Related]
3. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
Balcar-Boroń A; Nowaczyk-Michalak A; Graduszewska-Czerebiej K
Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
[No Abstract] [Full Text] [Related]
4. Intensive induction and consolidation chemotherapy for adults and children with acute myeloid leukaemia (AML) joint AML trial 1982-1985.
Marcus RE; Catovsky D; Prentice HG; Newland AC; Chessells JM; Stevens RF; Hann IM; Goldman JM; Hoffbrand AV; Galton DA
Haematol Blood Transfus; 1987; 30():346-51. PubMed ID: 2442074
[No Abstract] [Full Text] [Related]
5. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
6. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
7. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484
[No Abstract] [Full Text] [Related]
8. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
[No Abstract] [Full Text] [Related]
9. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
Rees JK; Gray R; Hayhoe FG
Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
[No Abstract] [Full Text] [Related]
10. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
11. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
[No Abstract] [Full Text] [Related]
12. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
[No Abstract] [Full Text] [Related]
13. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
Creutzig U; Ritter J; Riehm H; Budde M; Schellong G
Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
[No Abstract] [Full Text] [Related]
14. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig WD
Haematol Blood Transfus; 1990; 33():261-6. PubMed ID: 2182419
[No Abstract] [Full Text] [Related]
15. Contribution of clonogenic leukemic cell characteristics to therapy outcome in patients with acute myeloblastic leukemia.
Aul C; Heyll A
Haematol Blood Transfus; 1987; 30():356-60. PubMed ID: 3476367
[No Abstract] [Full Text] [Related]
16. Influence of daunorubicin and cytarabine sequencing on the outcome of therapy in acute myelogenous leukemia: a randomized trial.
Archimbaud E; Fiere D; Treille-Ritouet D; Adeleine P; Guyotat D; Sebban C; Vuvan H; Viala JJ
Cancer Treat Rep; 1987 Jun; 71(6):571-4. PubMed ID: 3555788
[TBL] [Abstract][Full Text] [Related]
17. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
[No Abstract] [Full Text] [Related]
18. Chemotherapy of adult acute myeloid leukaemia.
Suri R; Kueh YK; Han P; Tan YO
Ann Acad Med Singap; 1990 Mar; 19(2):175-7. PubMed ID: 2346291
[TBL] [Abstract][Full Text] [Related]
19. Extension of remission in acute nonlymphocytic leukemia.
Dutcher JP; Wiernik PH
J Clin Oncol; 1988 Nov; 6(11):1783-4. PubMed ID: 3054006
[No Abstract] [Full Text] [Related]
20. Postremission induction intensive sequential chemotherapy for children with AML--treatment results and prognostic factors.
Weinstein H; Grier H; Gelber R; Camitta B; Link M; Delorey M; Price K
Haematol Blood Transfus; 1987; 30():88-92. PubMed ID: 3476388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
